Neoprobe Commences Lymphoseek Phase 3 Trial-multicenter Clinical Study Of Patients With Breast Cancer Or Melanoma Initiated

July 2nd, 2008 by admin

DUBLIN, river — Neoprobe Corporation, a heterogeneous developer of original oncology and cardiovascular preoperative and characteristic products, today declared that a multicenter Phase 3 think of Lymphoseek(R) has been initiated in patients with either boob cancer or melanoma. The Phase 3 think module appraise the effectualness of Lymphoseek to refer lymph nodes that haw be prophetic of determining whether a patient’s cancer has distribute into the lymphatic system. The Phase 3 think has been qualified on the domestic clinical trials website www.clinicaltrials.gov. king Bupp, Neoprobe’s President and CEO, said, “Neoprobe is entertained to foretell the institution of its prototypal Phase 3 think (NEO3-05) for Lymphoseek. At the inform time,…

Tags: , , , ,

Posted in Cancer |

Related posts

Comments are closed.